Literature DB >> 24533234

The association between adiposity and breast cancer recurrence and survival: A review of the recent literature.

Maria Azrad1, Wendy Demark-Wahnefried2.   

Abstract

Breast Cancer (BC) is the most common and second deadliest malignancy among American women. Many factors contribute to BC prognosis but a key modifiable lifestyle factor is body weight. In this review, we update the reader on the association between adiposity and poor BC outcomes. We summarize the findings from studies that show obesity to be a risk factor for BC recurrence and reduced survival, including research that shows that treatment with aromatase inhibitors in hormone-receptor positive BC survivors who are obese may not be as effective as in normal weight women. In addition, we summarize the findings from studies that show that obesity-induced changes in glucose metabolism, type-2 diabetes and metabolic syndrome contribute to negative outcomes in BC survivors. Given the evidence, there is a critical need to determine whether weight loss can improve outcomes in BC survivors.

Entities:  

Keywords:  HOMA; adiposity; aromatase; aromatase inhibitor; body fat; body mass index; body weight; breast neoplasms; c-peptide; estrogen; estrogen-receptor positive; glucose; glucose metabolism; hormone-receptor positive; hormones; insulin; metabolic syndrome; mortality; obesity; overweight; recurrence; survival; type 2 diabetes

Year:  2014        PMID: 24533234      PMCID: PMC3921906          DOI: 10.1007/s13668-013-0068-9

Source DB:  PubMed          Journal:  Curr Nutr Rep        ISSN: 2161-3311


  34 in total

1.  Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.

Authors:  Tone Bjørge; Annekatrin Lukanova; Håkan Jonsson; Steinar Tretli; Hanno Ulmer; Jonas Manjer; Tanja Stocks; Randi Selmer; Gabriele Nagel; Martin Almquist; Hans Concin; Göran Hallmans; Christel Häggström; Pär Stattin; Anders Engeland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07       Impact factor: 4.254

2.  Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study.

Authors:  Melinda L Irwin; Catherine Duggan; Ching-Yun Wang; Ashley Wilder Smith; Anne McTiernan; Richard N Baumgartner; Kathy B Baumgartner; Leslie Bernstein; Rachel Ballard-Barbash
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

3.  Effect of obesity on prognosis after early-stage breast cancer.

Authors:  Marianne Ewertz; Maj-Britt Jensen; Katrín Á Gunnarsdóttir; Inger Højris; Erik H Jakobsen; Dorte Nielsen; Lars E Stenbygaard; Ulla B Tange; Søren Cold
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

4.  Diabetes and cancer: a consensus report.

Authors:  Edward Giovannucci; David M Harlan; Michael C Archer; Richard M Bergenstal; Susan M Gapstur; Laurel A Habel; Michael Pollak; Judith G Regensteiner; Douglas Yee
Journal:  CA Cancer J Clin       Date:  2010-06-16       Impact factor: 508.702

5.  Obesity and weight change in relation to breast cancer survival.

Authors:  Xiaoli Chen; Wei Lu; Wei Zheng; Kai Gu; Zhi Chen; Ying Zheng; Xiao Ou Shu
Journal:  Breast Cancer Res Treat       Date:  2010-01-08       Impact factor: 4.872

6.  Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.

Authors:  Raimund Jakesz; Richard Greil; Michael Gnant; Marianne Schmid; Werner Kwasny; Ernst Kubista; Brigitte Mlineritsch; Christoph Tausch; Michael Stierer; Friedrich Hofbauer; Karl Renner; Christian Dadak; Ernst Rücklinger; Hellmut Samonigg
Journal:  J Natl Cancer Inst       Date:  2007-12-11       Impact factor: 13.506

7.  The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial.

Authors:  Evandro de Azambuja; Worta McCaskill-Stevens; Prudence Francis; Emmanuel Quinaux; John P A Crown; Malou Vicente; Rosa Giuliani; Bo Nordenskjöld; Jorge Gutiérez; Michael Andersson; Mireia Margeli Vila; Raimund Jakesz; Jan Demol; Joanna Dewar; Armando Santoro; Ana Lluch; Steven Olsen; Richard D Gelber; Angelo Di Leo; Martine Piccart-Gebhart
Journal:  Breast Cancer Res Treat       Date:  2010-01       Impact factor: 4.872

8.  Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.

Authors:  Marianne Schmid; Raimund Jakesz; Hellmut Samonigg; Ernst Kubista; Michael Gnant; Christian Menzel; Michael Seifert; Karin Haider; Susanne Taucher; Brigitte Mlineritsch; Peter Steindorfer; Werner Kwasny; Michael Stierer; Christoph Tausch; Michael Fridrik; Viktor Wette; Günther Steger; Hubert Hausmaninger
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

9.  Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer.

Authors:  Elizabeth J Folkerd; J Michael Dixon; Lorna Renshaw; Roger P A'Hern; Mitch Dowsett
Journal:  J Clin Oncol       Date:  2012-07-16       Impact factor: 44.544

10.  Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial.

Authors:  Ivana Sestak; Wolfgang Distler; John F Forbes; Mitch Dowsett; Anthony Howell; Jack Cuzick
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544

View more
  41 in total

Review 1.  Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti-tumor immunity.

Authors:  Laura M Sipe; Mehdi Chaib; Ajeeth K Pingili; Joseph F Pierre; Liza Makowski
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

2.  Survivorship care plans and time since diagnosis: factors that contribute to who breast cancer survivors see for the majority of their care.

Authors:  Kara P Wiseman; Diane L Bishop; Qin Shen; Resa M Jones
Journal:  Support Care Cancer       Date:  2015-02-10       Impact factor: 3.603

3.  Feasibility study to evaluate compliance of physical activity over a long time period and its influence on the total activity score, glucose metabolism and physical and psychological parameters following breast cancer.

Authors:  Thorsten Schmidt; Madalena Schwarz; Marion Van Mackelenbergh; Walter Jonat; Burkhard Weisser; Christoph Röcken; Christoph Mundhenke
Journal:  Mol Clin Oncol       Date:  2017-01-31

4.  Obesity and Breast Cancer: Do Age, Race and Subtype Matter?

Authors:  Kimberly M Arnold; Nicole J Flynn; Jennifer Sims-Mourtada
Journal:  BAOJ Cancer Res Ther       Date:  2016-02-15

5.  Induction of IL-6 by Cytotoxic Chemotherapy Is Associated With Loss of Lean Body and Fat Mass in Tumor-free Female Mice.

Authors:  Collin R Elsea; Janet A Kneiss; Lisa J Wood
Journal:  Biol Res Nurs       Date:  2014-11-18       Impact factor: 2.522

Review 6.  Morbidity and mortality associated with obesity.

Authors:  Mahmoud Abdelaal; Carel W le Roux; Neil G Docherty
Journal:  Ann Transl Med       Date:  2017-04

7.  Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review.

Authors:  Melika Shirdarreh; Rossanna C Pezo
Journal:  Breast Cancer       Date:  2021-01-11       Impact factor: 4.239

Review 8.  Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer.

Authors:  Crystal C Lipsey; Adriana Harbuzariu; Danielle Daley-Brown; Ruben R Gonzalez-Perez
Journal:  World J Methodol       Date:  2016-03-26

9.  The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436).

Authors:  Vicki A Morrison; Linda McCall; Hyman B Muss; Aminah Jatoi; Harvey J Cohen; Constance T Cirrincione; Jennifer A Ligibel; Jacqueline M Lafky; Arti Hurria
Journal:  J Geriatr Oncol       Date:  2017-12-08       Impact factor: 3.599

Review 10.  Obesity and cancer: mechanistic insights from transdisciplinary studies.

Authors:  Emma H Allott; Stephen D Hursting
Journal:  Endocr Relat Cancer       Date:  2015-09-15       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.